HELSINKI Feb 5 Finnish drug maker Orion
reported a weaker-than-expected quarterly profit and
forecast a slight fall in operating profit this year amid
increasing generic competition for its Parkinson's drugs.
Orion's quarterly operating profit was little changed from a
year earlier at 59.4 million euros ($80.5 million), weaker than
the market's average forecast of 63 million euros in a Reuters
Orion said sales of products other than its Parkinson's
drugs will grow, helping full-year net sales to be similar to
the 980 million euros ($1.33 billion) reported for 2012, but
that margins would be lower.
($1 = 0.7376 euros)
(Reporting by Helsinki Newsroom)